Company Quick10K Filing

Quick10K

⚲

Advantego

Filings

10-Q	2019-09-30	Filed 2019-11-19
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-01
10-Q	2018-09-30	Filed 2018-11-13
S-1	2018-08-02	Public Filing
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-21
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-28
10-Q	2017-06-30	Filed 2017-11-22
10-Q	2017-03-31	Filed 2017-11-21
10-K	2016-12-31	Filed 2017-10-19
10-Q	2016-09-30	Filed 2017-04-05
10-Q	2016-06-30	Filed 2016-09-07
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2017-08-04
10-Q	2015-06-30	Filed 2015-12-01
10-Q	2015-06-30	Filed 2015-12-01
10-Q	2015-03-31	Filed 2015-12-01
10-K	2014-12-31	Filed 2017-08-03
10-Q	2014-09-30	Filed 2015-11-25
10-Q	2014-06-30	Filed 2015-11-09
10-Q	2014-03-31	Filed 2015-11-04
10-K	2013-12-31	Filed 2017-03-27
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15
10-K	2012-12-31	Filed 2013-04-01
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-07-31
10-Q	2012-03-31	Filed 2012-05-11
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-12
10-K	2010-12-31	Filed 2011-04-12
10-Q	2010-09-30	Filed 2010-11-22
10-Q	2010-06-30	Filed 2010-08-20
10-Q	2010-03-31	Filed 2010-05-24
10-K	2009-12-31	Filed 2010-05-14

Reports

8-K	2020-05-20
8-K	2020-05-19
8-K	2020-03-30
8-K	2020-03-06
8-K	2020-02-28
8-K	2020-01-17
8-K	2019-12-12
8-K	2019-05-26
8-K	2019-03-14
8-K	2019-01-14
8-K	2018-12-18
8-K	2018-07-20
8-K	2018-06-11
8-K	2018-05-31
8-K	2018-03-02
8-K	2018-02-05
8-K	2018-01-31

Advantego Financials

ADGO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Cash	271	119	78	39	9	8	18	4	14	3	13	0	46	44	15	2	37	92	423	135
Accounts Receivable	9	7	8	1	0	0									2	6		25	21	68
Inventory																	1	6	5	0
PP&E	3,989	3,989	3,989	3,980	3,980	3,980	3,980	3,980	3,980	350	350	350
Assets	4,723	4,566	4,498	4,385	4,283	4,103	4,028	3,986	3,997	354	364	350	46	44	18	8	38	195	546	554
Accounts Payable										12	9	4	4	4	4	8	27	16	70	112
Long-Term Debt						350							43	95
Liabilities	283	130	145	7	384	376	403	435	748	757	856	925	196	358	492	612	650	1,656	4,445	4,782
Stockholders' Equity	4,440	4,436	4,353	4,377	3,899	3,727	3,625	3,551	3,249	-403	-492	-575	-150	-314	-474	-604	-612	-1,461	-3,899	-4,228


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Revenue	0	0	0	0	0	0	0	0	0					0	3	6			8	21
Cost of Revenue																			11	15
Gross Profit																			-3	6
R&D
SG&A	222	169	173	153	93	76	87	66	27				-27	160	158	130	124		348	304
Tax	0	0	0	0	0	0	0	0	0	0				0	0	0	0		0	0
Net Income	-249	-79	-229	-237	-482	-189	-291	62	-303	-3,670			2	-165	-160	-130	-163		-600	-745


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-12-31	2019-03-31	2019-06-30
Cash Operating		-149	-146	-131	-413	-130	-64	-33	-316	250			-6	-52	-41		-77		-557	-772
Cash Investing		-3	105	26	33	129	74	19	0	1									0	0
Cash Financing		0	0	66	350				327	-262				50	12		112		889	484